---
document_datetime: 2025-02-13 10:47:14
document_pages: 12
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/xaluprine-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: xaluprine-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 7.1052923
conversion_datetime: 2025-12-19 10:48:28.275608
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Xaluprine

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0042/G            | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.z - Changes (Safety/Efficacy) of Human and | 10/01/2025                          | 10/02/2025                                  | SmPC, Labelling and PL           |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                    | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |            |             |                                                                                                                                           |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0041/G          | This was an application for a group of variations. B.II.e.z - Change in container closure system of the Finished Product - Other variation B.II.e.z - Change in container closure system of the Finished Product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 10/07/2024 | n/a        |             |                                                                                                                                           |
| PSUSA/1988/ 202309 | Periodic Safety Update EU Single assessment - mercaptopurine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 25/04/2024 | 20/06/2024 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1988/202309. |
| IAIN/0040          | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 08/12/2023 | n/a        |             |                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|                    | not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |            |                 |                                                                                                                                           |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0038/G        | This was an application for a group of variations. B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - | 17/05/2023 | 15/11/2023 | SmPC and PL     |                                                                                                                                           |
| IA/0037/G          | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 09/11/2022 | 15/11/2023 | Annex II and PL |                                                                                                                                           |
| PSUSA/1988/ 202109 | Periodic Safety Update EU Single assessment - mercaptopurine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 22/04/2022 | 21/06/2022 | SmPC and PL     | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1988/202109. |

<div style=\"page-break-after: always\"></div>

| IB/0035   | - Change in test procedure for the finished - Other changes to a test procedure replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                | 28/04/2022   | n/a        |      | B.II.d.2.d product (including   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------|---------------------------------|
| IA/0036/G | This was an application for a group of variations. B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect | 21/04/2022   | n/a        |      | the product information         |
| IB/0033/G | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.e - Stability of FP - Change to an approved stability protocol                                                                                                                                                                                                                                                    | 12/01/2022   | 21/06/2022 | SmPC |                                 |
| IB/0032/G | This was an application for a group of variations. B.II.d.1.d - Change in the specification parameters and/or limits of the finished product - Deletion of a non-significant specification parameter B.II.d.1.d - Change in the specification parameters                                                                                                                                                                                                                                                                | 02/07/2021   | n/a        |      |                                 |

<div style=\"page-break-after: always\"></div>

|           | product - Deletion of a non-significant specification parameter B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation   |            |            |                 | and/or limits of the finished   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|---------------------------------|
| IA/0031   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                       | 19/05/2021 | n/a        |                 |                                 |
| IA/0030   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                     | 03/03/2021 | 16/04/2021 | Annex II and PL |                                 |
| IAIN/0029 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                            | 02/02/2021 | 16/04/2021 | Annex II and PL |                                 |
| IA/0028   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                       | 09/12/2020 | n/a        |                 |                                 |
| IA/0027   | B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non-                                                                                                                                                                                                                                                                                                                                                               | 30/10/2020 | n/a        |                 |                                 |

<div style=\"page-break-after: always\"></div>

|           | sterile medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |                       |                                                                                                                                                                                        |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0026/G | This was an application for a group of variations. B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a | 05/08/2020 | n/a        |                       |                                                                                                                                                                                        |
| II/0022   | Update of section 4.8 of the SmPC to add Portal hypertension, nodular regenerative hyperplasia and sinusoidal obstruction syndrome. The MAH took the opportunity to implement minor editorial changes to the SmPC, Annex II and PIL. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 30/04/2020 | 16/04/2021 | SmPC, Annex II and PL | The SmPC has been updated to include the adverse drug reactions: Portal hypertension, nodular regenerative hyperplasia and sinusoidal obstruction syndrome, with a frequency uncknown. |

<div style=\"page-break-after: always\"></div>

| IB/0025     | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                                                                       | 15/04/2020   | n/a        |                 |             |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-------------|
| IA/0024     | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                         | 11/12/2019   | n/a        |                 |             |
| IAIN/0023/G | This was an application for a group of variations. B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - CE marking | 05/09/2019   | n/a        |                 | Device with |
| IAIN/0021/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP -                                                                                                                                                                                                                                                                                                                                                                             | 24/04/2019   | 08/04/2020 | Annex II and PL |             |

<div style=\"page-break-after: always\"></div>

|           | of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                                       |            |            |                        | Replacement or addition   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------------------|
| T/0020    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 20/12/2018 | 31/01/2019 | SmPC, Labelling and PL |                           |
| IB/0019/G | This was an application for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) | 30/01/2019 | n/a        |                        |                           |
| IA/0018   | B.III.1.a.2 - Submission of a new/updated or                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 26/11/2018 | n/a        |                        |                           |

<div style=\"page-break-after: always\"></div>

|                    | deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                       |            |            |                                  |                                                                                                                                                                                                                                                                         |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0017             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                     | 14/11/2018 | 31/01/2019 | Labelling                        |                                                                                                                                                                                                                                                                         |
| IB/0016/G          | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) B.II.f.1.e - Stability of FP - Change to an approved stability protocol | 23/10/2018 | 31/01/2019 | SmPC                             |                                                                                                                                                                                                                                                                         |
| IA/0015            | B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products                                                                                                                                       | 18/08/2017 | n/a        |                                  |                                                                                                                                                                                                                                                                         |
| PSUSA/1988/ 201609 | Periodic Safety Update EU Single assessment - mercaptopurine                                                                                                                                                                                                         | 18/05/2017 | 13/07/2017 | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1988/201609.                                                                                                                               |
| R/0012             | Renewal of the marketing authorisation.                                                                                                                                                                                                                              | 15/09/2016 | 18/11/2016 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Xaluprine in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IAIN/0013          | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                       | 09/06/2016 | 18/11/2016 | SmPC and PL                      |                                                                                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

| IAIN/0011   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location   | 29/07/2015   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                 |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUV/0008   | Periodic Safety Update                                                                                                                                            | 25/09/2014   | 19/11/2014 | SmPC and PL | Please refer to Xaluprine (EMEA/H/C/2022/PSUV/0008) EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation                                                                                                                                                                                             |
| IAIN/0010   | C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV and/or QPPV contact details and/or back-up procedure      | 17/10/2014   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                 |
| IAIN/0009   | C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV and/or QPPV contact details and/or back-up procedure      | 16/06/2014   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                 |
| IAIN/0007   | C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV and/or QPPV contact details and/or back-up procedure      | 21/03/2014   | n/a        |             |                                                                                                                                                                                                                                                                                                                                                                 |
| PSUV/0006   | Periodic Safety Update                                                                                                                                            | 24/10/2013   | 20/12/2013 | SmPC and PL | Update of Sections 4.4 and 4.8 of the SmPC to add a warning on hepatosplenic T cell lymphoma and lymphoproliferative disorders and to add the adverse reaction hepatosplenic T cell lymphoma and lymphoproliferative disorders with a frequency unknown. The Package leaflet is to be updated accordingly. Please refer to: Xaluprine-H-C-2022-PSUV-0006 EPAR - |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            |                        | Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------|
| IB/0004   | B.II.f.1.b.2 - Stability of FP - Extension of the shelf life of the finished product - After first opening (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 11/03/2013 | 20/12/2013 | SmPC, Labelling and PL |                                                                                                             |
| IAIN/0005 | B.III.1.a.1 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 05/03/2013 | n/a        |                        |                                                                                                             |
| II/0002/G | This was an application for a group of variations. The preservative system of the finished product Xaluprine has been revised: changes involve deletion of propyl parahydroxybenzoate and replacement with ethyl parahydroxybenzoate, sodium salt and potassium sorbate, sodium salt of methyl parahydroxybenzoate. In addition revision to the manufacturing process and the test procedures have been performed with the new formulation. B.II.a.3.b.2 - Changes in the composition (excipients) of the finished product - Other excipients - Qualitative or quantitative changes in one or more excipients that may have a significant impact on the safety, quality or efficacy of the product B.II.b.3.z - Change in the manufacturing process of the finished product - Other variation | 20/09/2012 | 15/11/2012 | SmPC, Labelling and PL |                                                                                                             |

<div style=\"page-break-after: always\"></div>

|           | Other changes to a test procedure (including replacement or addition) B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation   |            |            |                        | product -   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------|
| IAIN/0003 | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                | 15/08/2012 | n/a        |                        |             |
| IAIN/0001 | A.2.a - Administrative change - Change in the (invented) name of the medicinal product for CAPs                                                                                                    | 11/05/2012 | 15/11/2012 | SmPC, Labelling and PL |             |